Concepedia

George Doherty

GD

22

Publications

2.1K

Citations

18

H-Index

2000

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Oxford

Public Health England

Oxford University Hospitals NHS Trust

AbbVie (United States)

George Doherty is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2000–2024

22

Publications

22

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

Mark Ainsworth, Monique Andersson, Kathryn Auckland et al. · The Lancet Infectious Diseases · 2020 · 397 citations · Full text

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers

Sheila Lumley, Jia Wei, Denise O’Donnell et al. · Clinical Infectious Diseases · 2021 · 306 citations · Full text

Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study

David W. Eyre, Sheila Lumley, Denise O’Donnell et al. · eLife · 2020 · 282 citations · Full text

Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey

Koen B. Pouwels, Thomas House, Emma Pritchard et al. · The Lancet Public Health · 2020 · 208 citations · Full text

, , +8

An Asymmetric Synthesis of the Tricyclic Core and a Formal Total Synthesis of Roseophilin via an Enyne Metathesis

Barry M. Trost, George Doherty · Journal of the American Chemical Society · 2000 · 174 citations

Rows per page

1–5 of 22